MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2019 International Congress

    Smell and taste in cervical dystonia: a contribution to understand dystonia pathophysiology.

    T. Herr, T. Hummel, M. Vollmer, C. Willert, B. Lehnert, M. Kronenbürger (Greifswald, Germany)

    Objective: To contribute to the better understanding of the pathophysiology of cervical dystonia (CD) we systematically assessed olfactory and gustatory functioning in CD subjects and…
  • 2019 International Congress

    Substantia Nigra Hyperechogenicity in Parkinson’s Disease and Essential Tremor and its Association with Premotor Symptoms of Parkinson’s Disease

    M. Uribe Roca, A. Chertcoff, L. Bandeo, M. Saucedo, F. Pantiu, L. de Francesco, L. Leon Cejas, M. Pacha, G. Napoli, P. Bonardo, O. Martinez, M. Fernandez Pardal, R. Reisin (Buenos Aires, Argentina)

    Objective: To compare the frequency of Substantia Nigra hyperechogenicity (SN+) in patients with essential tremor (ET) and Parkinson’s disease (PD), to determine the frequency of…
  • 2019 International Congress

    Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease

    D. Roos, J. Twisk, P. Raijmakers, R. Doty, H. Berendse (Amsterdam, Netherlands)

    Objective: To determine the relationship of anosmia/hyposmia in Parkinson’s disease (PD) with other motor and non-motor symptoms, and with the degree of nigrostriatal dopaminergic cell…
  • 2019 International Congress

    Specific chemosensory pattern in Parkinson’s disease

    C. Tremblay, R. Emrich, A. Cavazzana, L. Klingelhoefer, M. Brandt, T. Hummel, A. Haehner, J. Frasnelli (Trois-Rivières, QC, Canada)

    Objective: Our objective was to investigate the trigeminal pathway by measuring intranasal and central electrophysiological recordings in response to a specific trigeminal stimulus in patients…
  • 2019 International Congress

    Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

    Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

    Objective: To characterize olfactory impairment in Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Background: In the previous study, we found…
  • 2019 International Congress

    Retronasal olfactory function in Parkinson’s disease

    E. Aubry-Lafontaine, C. Tremblay, P. Durand-Martel, N. Dupré, J. Frasnelli (Trois-Rivières, QC, Canada)

    Objective: The objective of this study was to compare orthonasal and retronasal olfactory function in PD patients and compare them to NPOD participants and to…
  • 2019 International Congress

    Non motor symptoms Parkinson’s disease

    N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

    Objective: 1.To identify the representation and prevalence of non-motor symptoms of PD in the premotor and early motor stages Background: During the period 2016-2018 104 people were…
  • 2019 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…
  • 2019 International Congress

    Path to Prevention (P2P) – Developing a Prodromal PD Progression Biomarker Program

    K. Marek, A. Siderowf, C. Coffey, T. Foroud, V. Arnedo, E. Flagg, S. Chowdhury, K. Kieburtz, L. Chahine, J. Seibyl (New Haven, CT, USA)

    Objective: The overall objective of the Path to Prevention (P2P) initiative is to identify clinical, imaging, and biologic markers of progression during the prodromal phase…
  • 2019 International Congress

    Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

    B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

    Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease. Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley